ArticleJournal of oncology2021

Combination of the EP and Anti-PD-1 Pathway or Anti-CTLA-4 for the Phase III Trial of Small-Cell Lung Cancer: A Meta-Analysis.

Abdulhakim A A Abunasser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.